Illustrative sample. Fictional company and synthetic data, shown to demonstrate format and methodology. No real prospect, client, or contact information appears on this page.
LOS BRAVOS | LEAD INTELLIGENCE PACKET
Industrial & Commercial Real Estate
✓ Company Identified ✓ Research Complete ⚠ Contact Research Needed → HIGH PRIORITY TARGET
Meridian NeuroDevices, Inc.
Minneapolis, MN · Implantable neurostimulation systems (Class II/III medical devices) · No Mexico facility yet, active nearshoring evaluation
The VP of Global Manufacturing Operations owns site selection and capacity planning for a medical-device manufacturer at this stage. Okafor (illustrative) is the executive who signs off on where new assembly capacity lands and who scopes the build requirements, which makes him the right entry point for a build-to-suit conversation rather than a procurement or facilities contact further down the chain.
Company Intelligence
HQ
Minneapolis, Minnesota
Parent
Independent, publicly traded (illustrative)
Industry
Class II/III medical devices: implantable neurostimulation systems and pulse generators
Capabilities
Cleanroom assembly, micro-electronics, sterile packaging, in-house R&D and regulatory
Footprint
Two US plants (Minnesota, Texas) and one Costa Rica facility
Juárez Facility
None yet. North American site selection reported to be underway
Status
HIGH PRIORITY TARGET
Why They'll Expand
Capacity utilization: US plants running near 92% on recent earnings commentary, leaving little headroom for projected 2026 to 2027 volume.
Capex commitment: a multi-year capacity expansion was announced, with "cost-competitive North American manufacturing" named as a priority.
Mexico-tagged hiring: open supply-chain and quality-engineering roles reference a "new North American site, location to be determined."
FDA clearance: a recent 510(k) clearance for a next-generation device line is expected to drive volume the current plants cannot absorb.
Leadership commentary: the CFO referenced nearshoring a portion of assembly to lower landed cost and reduce tariff exposure.
"We are actively evaluating additional North American manufacturing capacity to support the next phase of demand, with a focus on cost-competitive sites close to our US distribution network."
Attributed to CFO commentary, quarterly earnings call (illustrative)
Approach Strategy
Lead with fit, not availability. Juárez already hosts a dense medical-device cluster and a trained cleanroom workforce, which de-risks a first Mexico site for a Class II/III manufacturer. Open with cleanroom-ready Class A space, cross-border logistics through the El Paso port of entry, and a build-to-suit option that compresses time to first production. Frame Los Bravos as the partner that removes the site-selection unknowns rather than as a landlord pitching square footage.
Follow-Up Sequence
Day 7: Send the Juárez medical-device cluster brief plus a one-page site overview. No ask beyond a 20-minute intro call.
Day 14: If no reply, share a comparable build-to-suit timeline and a landed-cost snapshot versus the current footprint.
Day 30: Final touch with an open invitation to a site visit, then move to a quarterly nurture cadence if still no response.
Research Sources
Company press release (capacity expansion announcement)
LinkedIn (executive profile and open-roles review)